Connect with us

Technology

Power Wins DPHARM Idol Disrupt, Building the Best Place for People to Connect with Medical Research Online

Published

on

The First Digital Network for Research Flips the Script on Patient Recruitment

PHILADELPHIA, Oct. 2, 2024 /PRNewswire/ — Power, a leading digital platform for patient recruitment, was named the winner of DPHARM Idol Disrupt at the 14th annual DPHARM: Disruptive Innovations to Advance Clinical Research event, held on September 18. The platform introduced a novel AI-driven approach to deliver highly qualified patient referrals that align with protocol criteria, while supporting patients through each step of enrollment.

“Roughly 86% of all clinical trials are delayed due to an inability to recruit enough patients. By making it dead simple to discover and evaluate novel therapies, we’re hoping to offer patients a source of hope while reducing the time it takes for new breakthrough drugs to reach approval,” said Brandon Li, Co-Founder at Power

Revolutionizing the Clinical Trial Journey

Power is the first digital network for research, operating much like a Zillow, Airbnb, and LinkedIn—but for clinical trials. It offers patients an accessible way to explore treatment options, while helping researchers and trial sites recruit qualified participants faster than ever. The platform’s user-friendly design and AI-powered tools transform complicated clinical trial jargon into lay-friendly language, making it easier for patients to learn about and evaluate different trial options.

Pioneering AI for Clinical Trials

Power was the first to use large language models (LLMs) like GPT-3 to translate complex clinical trial jargon into plain English. In 2021—prior to ChatGPT’s release—Power developed an AI-driven process to make trial information accessible to patients. Today, Power’s platform processes data from 150,000 trials, rewriting over 50 million words into patient-friendly language. This automation replaces what would have taken 375 years of manual writing, with Power’s AI pipeline running every night to keep information up to date.

A New Era for Patient-Centric Research

In addition to showcasing their innovation, Power demonstrated how their platform overcomes a major barrier in clinical trials: building trust with patients. Over 70% of patients using the platform voluntarily share their electronic medical records (EMRs), enabling Power to perform pre-screening and AI analysis. What once took an average of 60 days now happens in just 1 day through automation. This unprecedented patient engagement leads to faster, more qualified referrals to trial sites and significantly reduces the workload for clinical research coordinators.

By providing clear and accessible information, Power has also made strides in engaging underrepresented populations. Today, over 40% of Power’s user base consists of patients from historically underrepresented groups, contributing to more inclusive and diverse clinical trials.

“Before Power, I used to spend five hours per day filtering through hospital and clinic records and reaching out to people who I thought might qualify.” – Clinical Research Coordinator @ Mount Sinai

Building the Most Important Network in Life Science Research

Power is driving meaningful change in the clinical trials space by focusing on what matters most: making life-saving treatments accessible to patients, faster and with less complexity. By bridging the gap between patients and researchers, Power offers patients a source of hope while reducing the time it takes for new breakthrough drugs to reach approval.

About Power

At Power, we make it easy for patients to connect with leading medical research. Every day, people use withpower.com to sign up for clinical trials, and we connect them with researchers directly. We simplify recruitment with a novel AI approach, delivering qualified referrals that match protocol criteria and supporting the entire process through to enrollment, making us a favorite among research sites.

For more information about Power and its disruptive approach to clinical trial recruitment, please visit https://www.withpower.com/ or reach out at hello@withpower.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/power-wins-dpharm-idol-disrupt-building-the-best-place-for-people-to-connect-with-medical-research-online-302265991.html

SOURCE Power Life Sciences Inc.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

iFOREX Lists on London Stock Exchange, Supporting Focus Across Global and Indian Markets

Published

on

By

LONDON, April 17, 2026 /PRNewswire/ — iFOREX today announced its recent admission to the Main Market of the London Stock Exchange (LSE) under the ticker IFRX, at a market valuation of approximately £43.3 million. This milestone marks a significant step in the Company’s long-term growth strategy and supports its continued expansion across international markets, including a growing focus on India.

With over 30 years of experience in the online trading industry, iFOREX has established a strong global presence built on proprietary technology, consistent innovation, and disciplined risk management. The Company continues to deliver advanced trading solutions alongside a high standard of client support, designed to meet the evolving needs of retail traders in dynamic markets.

Through its proprietary web-based and mobile trading platforms, iFOREX provides access to over 900 financial instruments, including foreign exchange, commodities, indices, stocks, cryptocurrencies, and ETFs. The Company continuously enhances its technology and product offering to deliver a seamless, secure, and efficient trading experience for its global client base.

India represents an increasingly important market for iFOREX, supported by a rapidly growing base of digitally engaged traders and rising interest in global financial markets. The Company aims to strengthen its presence by offering localized support, tailored educational resources, and technology-driven solutions aligned with the needs of Indian traders.

The Company’s admission to the London Stock Exchange enhances its visibility and credibility as a global fintech provider, focusing on investing in platform development, optimizing client experience, and scaling its international operations to support long-term growth.

“Our listing on the London Stock Exchange represents an important milestone in iFOREX’s evolution as a global trading provider,” said Itai Sadeh, Chief Executive Officer of iFOREX. “We see significant potential in the Indian market, driven by strong demand for digital trading solutions and increasing participation in global markets. We remain committed to expanding our presence in India while continuing to invest in technology, innovation, and client experience.”

iFOREX will continue to monitor market developments, adapt its offering to the needs of traders across different regions, and focus on delivering reliable services, transparent trading conditions, and long-term value to its clients and stakeholders.

Find out more here: iFOREX Website

This press release is intended solely for media use. It is not meant for individual investors and does not contain personal advice or recommendations.

 

View original content:https://www.prnewswire.com/in/news-releases/iforex-lists-on-london-stock-exchange-supporting-focus-across-global-and-indian-markets-302755696.html

Continue Reading

Technology

iFOREX Lists on London Stock Exchange, offering Cryptocurrency trading (CFDs) Across Global and LATAM Markets

Published

on

By

LONDON, April 29, 2026 /PRNewswire/ — iFOREX today announced its admission to the Main Market of the London Stock Exchange (LSE) under the ticker IFRX, with a market valuation of approximately £43.3 million. This milestone represents a major step in the Company’s global growth strategy and supports its continued expansion across international markets, including cryptocurrency CFD trading for retail investors in Latin America (LATAM) and beyond.

The listing underscores iFOREX’s commitment to combining traditional financial instruments with the evolving opportunities presented by the cryptocurrency market. Over the past decade, iFOREX has offered retail traders access to a broad portfolio of crypto CFDs, including Bitcoin (BTC), Ethereum (ETH), Ripple (XRP), Litecoin (LTC), and a growing range of other digital assets, alongside forex, commodities, indices, equities, and ETFs. The Company’s proprietary online and mobile platforms allow traders to seamlessly navigate both crypto and traditional markets from a single interface.

With more than 25 years of experience in online trading, iFOREX has built a solid global presence based on proprietary technology, disciplined risk management, and continuous innovation. By integrating crypto trading alongside traditional instruments, the Company provides traders with diversified opportunities, enhanced liquidity, and sophisticated tools to manage risk and capitalize on market trends.

Latin America represents a particularly high-growth region for cryptocurrency trading, supported by increasing digital adoption, rising interest in global financial markets, and a growing number of self-directed retail investors. iFOREX is committed to strengthening its presence in the region by offering localized services, multilingual support, and educational resources specifically designed to help LATAM clients engage confidently with both crypto and forex markets.

The LSE listing enhances iFOREX’s credibility and visibility as a global fintech provider while supporting its strategy to expand crypto trading offerings, scale operations, and provide long-term value to clients and shareholders. The Company continues to focus on platform innovation, regulatory compliance, and the development of tools that allow traders to execute informed and secure transactions across all available markets.

Itai Sadeh, Chief Executive Officer of iFOREX, commented:

“Our admission to the Main Market of the London Stock Exchange represents a landmark moment for iFOREX and reflects our commitment to innovation in financial trading, including cryptocurrencies. Latin America presents strong growth potential in digital assets, and we are focused on providing robust, reliable platforms, localized education, and tools that empower traders to access opportunities across both crypto and traditional markets.”

Looking forward, iFOREX plans to expand its crypto product offering, explore emerging digital asset trends, and continue delivering a secure, innovative, and client-focused trading experience to retail investors worldwide.

 

View original content:https://www.prnewswire.co.uk/news-releases/iforex-lists-on-london-stock-exchange-offering-cryptocurrency-trading-cfds-across-global-and-latam-markets-302755709.html

Continue Reading

Technology

Temu and QIMA Partner to Strengthen Product Testing and Platform Compliance

Published

on

By

DUBLIN, April 29, 2026 /PRNewswire/ — Temu, the global e-commerce platform, and QIMA, a leading testing, inspection, and certification company, today announced a partnership to strengthen product compliance and safety across the Temu platform. Under the partnership, QIMA’s testing and certification services will be integrated directly into Temu’s Seller Center, making compliance resources accessible to sellers.

QIMA will deliver independent product testing, on-site factory inspections, seller training programs, and digital compliance tools. Product testing will cover four initial categories: electrical and electronic goods, jewelry and gemstones, food contact materials, and light industrial products. Testing will be conducted against applicable regulatory and safety standards. QIMA will also conduct on-site factory inspections for selected sellers to verify production processes and supply chain practices at the source.

The Temu-QIMA partnership also includes structured training programs designed to help sellers better understand testing standards and regulatory requirements across markets, along with regular roundtables and workshops on evolving rules, policy developments, and compliance approaches.

“As e-commerce platforms serve more markets and more product categories, independent compliance infrastructure becomes essential, not optional,” said Pierre-Nicolas Disser, CEO of Consumer Products, QIMA. “This partnership, and particularly the integration into Temu’s Seller Center, is a step toward making compliance testing and certification a routine part of how sellers operate. That’s exactly the kind of work QIMA’s global network was built for.”

The partnership with QIMA builds on Temu’s broader product safety and compliance program. In 2025, the company invested approximately US$100 million globally in compliance, product safety, and quality control, with plans to double that investment in 2026. To date, Temu has established cooperation with more than 60 independent testing institutions worldwide. The partnership with QIMA represents one of the first integration of third-party compliance tools directly into the Temu Seller Center workflow.

“Temu prioritizes the safety of products on our platform, and our partnership with QIMA is a concrete step in that direction,” said a Temu spokesperson. “Together with QIMA, we are focused on providing consumers with a safe and trustworthy shopping experience, while making compliance resources more accessible to sellers on our platform.”

About Temu

Temu is a global e-commerce platform connecting consumers with millions of manufacturers, brands, and business partners. Operating in more than 90 markets worldwide, Temu is committed to providing affordable, high-quality products that enable customers to live better lives.

About QIMA

At QIMA, we are on a mission to help our clients make products consumers can trust. We have developed compliance solutions for testing, inspection and certification (TIC) that enable supply chain agility, sustainability, and product innovation. Our services are used by 30,000 businesses globally in the consumer products, agri-food and life sciences industries. What truly sets us apart is our unique culture of relentless care for our clients, and a commitment to offering intuitive solutions that blend deep tech and human intelligence; this is how QIMA continues to disrupt the Testing, Inspection and Certification industry.

SOURCE Temu

Continue Reading

Trending